Article title: “Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma”
Authors: Siying Chen, Ti Meng, Xiaowei Zheng, Jiangxia Cai, Weipeng Zhang, Haisheng You, Jianfeng Xing and Yalin Dong
Journal: Journal of Drug Targeting
Citation details: Volume 26, Number 1, pages 27–35
DOI: https://doi.org/10.1080/1061186X.2017.1332066
When the above article was published online and in print, the is incorrect. In addition, a reference to our previous research is missing.
Below is the corrected version of and the citation to our previously published article has been inserted in the references.
Figure 2. Methotrexate-mediated resistance promotes the activation of PI3K/Akt pathway and impede cell apoptosis. Western blot detection (A) and quantitative analysis (B) of NPM, PTEN, p-Akt, t-Akt, Bcl-2 and Bax both in MCF-7/MTX cells under methotrexate treatment (2.8 μM). Relative protein expressions were presented as mean ± SD, β-actin was used as loading control, *P < 0.05, **P < 0.01 by ANOVA versus control group.
![Figure 2. Methotrexate-mediated resistance promotes the activation of PI3K/Akt pathway and impede cell apoptosis. Western blot detection (A) and quantitative analysis (B) of NPM, PTEN, p-Akt, t-Akt, Bcl-2 and Bax both in MCF-7/MTX cells under methotrexate treatment (2.8 μM). Relative protein expressions were presented as mean ± SD, β-actin was used as loading control, *P < 0.05, **P < 0.01 by ANOVA versus control group.](/cms/asset/9e4f156c-086d-4680-98e9-087975efc04b/idrt_a_2163109_f0002_b.jpg)
This article is available both online and in print. The online version has been corrected.